| 000 | 01792 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515211038.0 | ||
| 264 | 0 | _c20110111 | |
| 008 | 201101s 0 0 chi d | ||
| 022 | _a1007-3418 | ||
| 024 | 7 |
_a10.3760/cma.j.issn.1007-3418.2010.02.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Yan | |
| 245 | 0 | 0 |
_a[Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis]. _h[electronic resource] |
| 260 |
_bZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _cFeb 2010 |
||
| 300 |
_a109-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aWang, Jiang-bin | |
| 700 | 1 | _aXu, Jie | |
| 700 | 1 | _aJiao, Jian | |
| 700 | 1 | _aZhang, Yong-gui | |
| 700 | 1 | _aJi, Shang-wei | |
| 700 | 1 | _aZhao, Ping | |
| 700 | 1 | _aGuo, Hong-hua | |
| 700 | 1 | _aLi, Yan | |
| 700 | 1 | _aZhou, Chang-yu | |
| 773 | 0 |
_tZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _gvol. 18 _gno. 2 _gp. 109-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3760/cma.j.issn.1007-3418.2010.02.008 _zAvailable from publisher's website |
| 999 |
_c19564757 _d19564757 |
||